Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor Bevacizumab in cancer patients: A meta-analysis of randomized controlled trials Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Monday, February 22, 2010

Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor Bevacizumab in cancer patients: A meta-analysis of randomized controlled trials



abstract

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.